Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262

Watchlist Manager
Jiangsu Nhwa Pharmaceutical Co Ltd Logo
Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262
Watchlist
Price: 26.94 CNY 3.38%
Market Cap: 27.4B CNY
Have any thoughts about
Jiangsu Nhwa Pharmaceutical Co Ltd?
Write Note

Jiangsu Nhwa Pharmaceutical Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jiangsu Nhwa Pharmaceutical Co Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262
Cash from Financing Activities
-ÂĄ304.4m
CAGR 3-Years
1%
CAGR 5-Years
N/A
CAGR 10-Years
-34%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash from Financing Activities
-ÂĄ753.7m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash from Financing Activities
-ÂĄ2.1B
CAGR 3-Years
-52%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash from Financing Activities
-ÂĄ1.6B
CAGR 3-Years
-84%
CAGR 5-Years
-15%
CAGR 10-Years
-105%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash from Financing Activities
-ÂĄ3B
CAGR 3-Years
15%
CAGR 5-Years
20%
CAGR 10-Years
-19%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cash from Financing Activities
ÂĄ90.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jiangsu Nhwa Pharmaceutical Co Ltd
Glance View

Market Cap
27.1B CNY
Industry
Pharmaceuticals

Jiangsu Nhwa Pharmaceutical Co., Ltd. engages in the pharmaceutical production, research and development, and sales. The company is headquartered in Xuzhou, Jiangsu and currently employs 4,732 full-time employees. The company went IPO on 2008-07-23. The firm offers its pharmaceutical products under four categories, which consist of anesthetic medicines, including midazolam injections and etomidate fat emulsion pharmaceutical preparations injections; psychiatric medicines, including risperidone tablets and others; neurological medicines, including gabapentin capsules and others; bulk drugs, including fenofibrate and miconazole nitrate. The firm is also engaged in the pharmaceuticals trading business. Through its subsidiaries, the Company is also engaged in the Internet medical businesses. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
31.36 CNY
Undervaluation 14%
Intrinsic Value
Price

See Also

What is Jiangsu Nhwa Pharmaceutical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-304.4m CNY

Based on the financial report for Jun 30, 2024, Jiangsu Nhwa Pharmaceutical Co Ltd's Cash from Financing Activities amounts to -304.4m CNY.

What is Jiangsu Nhwa Pharmaceutical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-34%

Over the last year, the Cash from Financing Activities growth was -29%. The average annual Cash from Financing Activities growth rates for Jiangsu Nhwa Pharmaceutical Co Ltd have been 1% over the past three years , and -34% over the past ten years .

Back to Top